Delivery Order SPE2DB22D2009-SPE2DB24FL6HR
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,510,706 units of Methylphenidate ER 18 mg tablets in 100-count packages. The Firm Fixed Price contract, valued at $1,613.35, has a completion date of November 22, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,566,370,660 units of methylphenidate ER 18 mg tablets. The firm-fixed-price delivery order, valued at $5,038.82, has an ultimate completion date of November 8, 2024. The contract is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,564,604,935 units of Methylphenidate ER 27 mg tablets in 100-count packages, with a ceiling value of $3,128.56. The contract has a firm fixed price pricing type and is a delivery order without any set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,232.09 Firm Fixed Price delivery order is for the supply of 4,564,588,975 units of Methylphenidate ER 54 mg tablets. The contract has an ultimate completion date of May 14, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
- This federal contract award, valued at $3,103.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,566,495,038 units of Methylphenidate ER 54 mg tablets in 100-count bottles. The award has an ultimate completion date of November 20, 2024 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,465.50 firm fixed-price delivery order is for the supply of 4,566,667,863 units of Methylphenidate ER 54 MG tablets. The contract has a ceiling value of $1,465.50 and an ultimate completion date of December 11, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,667,447 tablets of Methylphenidate ER 54 mg. The delivery order, valued at $1,043.44, has a completion date of February 14, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,557,295,372 tablets of Methylphenidate ER 36 mg. The fixed-price, firm-fixed-price contract has a ceiling value of $26,189.22 and an ultimate completion date of May 19, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of 4,554,684,931 units of Methylphenidate ER 27 mg tablets in 90-count containers. The contract was awarded to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract, valued at $1,588.14, is a delivery order issued by the Defense Logistics Agency (DLA), a defense agency, with a completion date of September 8, 2021. The contract is a firm-fixed-price, non-set-aside award. AmerisourceBergen...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of 4,567,785,629 units of Methylphenidate ER 36 mg tablets in 100-count packages. The contract is a firm fixed-price Delivery Order with a ceiling value of $1,217.04 and an ultimate completion date of April 3, 2025. The contract is not designated as a set-aside award. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB24FL6HRDelivery Order
This federal contract award, with ID SPE2DB22D2009|SPE2DB24FL6HR, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,676,885 units of Methylphenidate ER 54 mg tablets in 100 count bottles. The contract has a firm fixed price of $3,626.65 and an ultimate completion date of November 2, 2023. There is no set-aside designation for this award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, which covers similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 11/1/23 |